Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2022 ∙ Bollaerts, K. Fletcher, M. A. Suaya, J. A. Hanquet, G. Baay, M. Gessner, B. D.

Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials

  • Newborn
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022

Recommendations from the Higher Council for Infectious Diseases for vaccination against pneumococcus for populations at risk adults (18 years and over) or aged 65 and over

  • Recommendation
  • Europe
  • Luxembourg
  • Pneumococcal disease
Download:
2022 ∙ ACIP

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

  • Recommendation
  • Americas
  • United States of America
  • Adults
  • Pneumococcal disease
Download:
2022 ∙ ACIP

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

  • Recommendation
  • Americas
  • United States of America
  • Children
  • Adolescents
  • Pneumococcal disease
Download:
2022 ∙ UNITAG

Advisory on switching PCV products from PCV10 – Synflorix to PCV10 - Pneumosil in Uganda’s routine immunization schedule

  • Recommendation
  • Africa
  • Uganda
  • Pneumococcal disease
Download:
2022 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination against pneumococcal disease for adults in Belgium

  • Recommendation
  • Europe
  • Belgium
  • Risk group
  • Pneumococcal disease
Download:
2022 ∙ ACIP

Updates from the Pneumococcal Vaccines Work Group

  • Background paper
  • Americas
  • United States of America
  • Pneumococcal disease
Download:
2021 ∙ Wang, B. C. Chaiyakunapruk, N. Zhu, S. Babigumira, J. B. Furnback, W. Chitale, R. Gamil, A. Zhao, K. Wasserman, M.

A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019)

  • Western Pacific
  • Children
  • Newborn
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Shao, Y. Stoecker, C.

Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review

  • Adults
  • Older adults
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Ishiwada, N.

Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan

  • Western Pacific
  • Japan
  • All age groups
  • Pneumococcal disease
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...